Loading company…
Wondfo develops diagnostic reagents, instruments, and testing platforms.
Founded in 1992, Wondfo develops diagnostic reagents and instruments for clinical testing, chronic disease management, epidemic monitoring, and disaster relief. Its platforms cover immunofluorescence, molecular diagnostics, and biochemical analysis. Based in Guangzhou, China, the company raised CNY 700 million from investors in April 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in